Stockrabit · Analysts
Questions across 8 calls

Madhur Rathi

Counter Cyclical Investments

Redington Limited

Redington Limited CC-Feb26.pdf · 2026-02-05
Sir, we had mentioned -- we were expecting the TSG deal segment to pick up in H2 of FY '26. But I think because of margin pressure and if you could just help us understand how do we see this segment scaling up because you have mentioned that there are clear headwinds that we see either on the shortage side or on the margin pressure side?
Sir, I wanted to understand regarding the ESG segment and what is the additional price hike do we expect from our discussions with the OEM? And the current -- what we understand is that there has been a 20% price hike. So is this passed on to the consumer level currently? Or this is currently on the distribution level and sooner or later -- and when do we expect this to be passed on to the consumer level? Because you mentioned that most of the demand currently is coming from our channel partners and the sub-distributors?
Redington Limited CC-Sep24.pdf · 2024-10-30
Sir, I understand that from the previous question, our gross margin has been pressured over the past few quarters due to various reasons. When I look at some business perspective, the 2.4% to 2.6% kind of margin raise on the operating level. It looks far size currently. As seen in the past 4 quarters, there has been some kind of externality that have been affecting our business. So when can we expect the initiative of margins to sustain for our business? Or do we see these kind of pressure for additional 4 to 6 quarters going forward? So some thought on that.
Do we have some kind of time line as we see that the larger deal as well as the externalities go away? Or do we think that this pressure would extend for some few quarters?

Zydus Wellness Limited

Zydus Wellness Limited CC-Mar25.pdf · 2025-05-19
Sir, thank you for the opportunity, Sir, I wanted to understand regarding our Rite Bite acquisition and the capital allocation policy regarding that. So, sir, if I consider the Complan and Glucon D brand that we bought for INR 4,600 crores in FY '19, sir, that has incrementally added only INR 100 crores to INR 150 crores in our PBT. So, sir, that is less than 3% yield, if I can understand and that too after 4, 5 years. So if I am trying to understand that some valuation multiple that you did for Rite Bite, and sir, how has the valuation policy changed in acquiring different businesses, post this disaster that we had for Complan, where considering inflation, it's even lower the incremental PBT that we have added.
Got it. So, if I look at our Company, so the main strategy that we are following is acquiring brands, dominantly market leaders in smaller segments and growing them out. So, sir, going forward, is there a certain criteria like IRR or a payback period we would expect before doing any of these internal acquisition going forward?
Zydus Wellness Limited CC-Dec23.pdf · 2024-02-08
Sir, I wanted to understand, when I look even on a Y-on-Y basis, our sales have declined, but we have gained share in a lot of our products where we are already market leader, we have gained additional share. So, if you could just help me understand why is that the FMCG market is growing but it's not moving into our sales growth?
Sir, when can we see, so you said that demand, but is there a time line in your mind as well as some kind of quantity, like number if you can say that we can grow at for FY '25 as well as FY '26?

Mahanagar Gas Limited

Indraprastha Gas Limited

Morepen Laboratories Limited